Acquired Bleeding Disorder
📧 Sign up to get email alerts when something new happens for Acquired Bleeding Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury
A completed clinical trial sponsored by Novo Nordisk evaluates the incidence and magnitude of hemorrhagic progression in cerebral contusions…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Recombinant Factor VIIa in Acute Intracerebral Haemorrhage [Phase 2]
A Phase 2 trial evaluating recombinant factor VIIa for acute intracerebral hemorrhage has completed; the study was sponsored by Novo Nordisk…
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Use of Activated Recombinant FVII in Spinal Surgery [Phase 2]
Phase 2 trial evaluating activated recombinant factor VII for controlling bleeding in spinal surgery has been completed. The sponsor studied…
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Use of NovoSeven® in Active Variceal Bleeding [Phase 2]
Phase 2 trial evaluating NovoSeven (recombinant activated factor VII) for active variceal bleeding in patients with cirrhosis has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII for Preventing Early Hematoma Growth in Acute Intracerebral Haemorrhage [Phase 2]
Phase 2 clinical trial update reporting safety and preliminary efficacy of recombinant activated factor VII to prevent early hematoma growth…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Activated Recombinant Human Factor VII Following Cardiac Bypass Surgery for Paediatric Congenital Heart Disease [Phase 3]
Phase 3 trial evaluating activated recombinant human factor VII for bleeding management during cardiopulmonary bypass in pediatric congenita…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Use of Activated Recombinant Human Factor VII in Cardiac Surgery [Phase 2]
Phase 2 trial evaluating activated recombinant human factor VII for bleeding control in cardiac surgery requiring cardiopulmonary bypass was…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Allogeneic Stem Cell Transplantation [Phase 2]
A Phase 2 clinical trial evaluating the safety and efficacy of activated recombinant human factor VII for treating bleeding in patients foll…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Safety of rFXIII in Patients Following First Time Myocardial Revascularization Requiring Cardiopulmonary Bypass [Phase 1]
Phase 1 safety trial of recombinant Factor XIII (rFXIII) in patients after first-time myocardial revascularization requiring cardiopulmonary…